Product Program year 2025 Source: CMS Open Payments

Epioxa

Drug Ophthalmology

Open in the dashboard

General payments

$391,963

137 payments

Research payments

$0

0 payments

Through program year 2025, $391,963 in general payments and $0 in research payments were reported against Epioxa (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $391,963 137

Breakdown

Who paid General payments · program year 2025
  1. Glaukos Corporation $391,963 137 payments
Top recipients General payments · program year 2025
  1. Kenneth Beckman Ophthalmology · Westerville, OH $15,850 4% · 4 payments
  2. Sila Bal Cornea and External Diseases Specialist · Honolulu, HI $13,650 3% · 2 payments
  3. Natalie Afshari Ophthalmology · La Jolla, CA $13,596 3% · 3 payments
  4. Duna Raoof Ophthalmology · Laguna Hills, CA $12,016 3% · 2 payments
  5. John Berdahl Ophthalmology · Sioux Falls, SD $11,257 3% · 2 payments

The top 5 of 83 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $320,213 85% · 60 practitioners
  2. Cornea and External Diseases Specialist Ophthalmology $46,885 12% · 6 practitioners
  3. Pediatric Ophthalmology and Strabismus Specialist Ophthalmology $6,300 2% · 1 practitioner
  4. Optometrist $4,422 1% · 13 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $55,696 14% · 19 recipients
  2. Massachusetts $28,560 7% · 4 recipients
  3. North Carolina $28,191 7% · 5 recipients
  4. Ohio $25,501 7% · 2 recipients
  5. Florida $22,784 6% · 4 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

137 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record